Inhibrx Biosciences, Inc. INBX Total Revenue
Discontinued — last reported Q4 '25
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Inhibrx Biosciences, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s total revenue?
- Inhibrx Biosciences, Inc. (INBX) reported total revenue of $0 in Q4 2025.
- How has Inhibrx Biosciences, Inc.'s total revenue changed year-over-year?
- Inhibrx Biosciences, Inc.'s total revenue decreased by 100.0% year-over-year, from $100K to $0.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s total revenue?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s total revenue has grown at a -15.0% compound annual growth rate (CAGR), from $1.8M to $1.3M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.